Novo Nordisk AS (NVO)
110.13
-1.81
(-1.62%)
USD |
NYSE |
Nov 04, 13:12
Novo Nordisk Total Liabilities (Quarterly): 36.87B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 36.87B |
| March 31, 2024 | 28.93B |
| December 31, 2023 | 30.87B |
| September 30, 2023 | 29.33B |
| June 30, 2023 | 27.77B |
| March 31, 2023 | 24.91B |
| December 31, 2022 | 22.71B |
| September 30, 2022 | 21.96B |
| June 30, 2022 | 20.28B |
| March 31, 2022 | 19.60B |
| December 31, 2021 | 18.84B |
| September 30, 2021 | 16.84B |
| June 30, 2021 | 14.81B |
| March 31, 2021 | 13.07B |
| December 31, 2020 | 13.49B |
| September 30, 2020 | 12.67B |
| June 30, 2020 | 11.48B |
| March 31, 2020 | 10.61B |
| December 31, 2019 | 10.20B |
| September 30, 2019 | 10.54B |
| June 30, 2019 | 9.876B |
| March 31, 2019 | 9.440B |
| December 31, 2018 | 9.027B |
| September 30, 2018 | 8.461B |
| June 30, 2018 | 8.402B |
| Date | Value |
|---|---|
| March 31, 2018 | 8.154B |
| December 31, 2017 | 8.467B |
| September 30, 2017 | 8.064B |
| June 30, 2017 | 7.598B |
| March 31, 2017 | 7.744B |
| December 31, 2016 | 7.433B |
| September 30, 2016 | 6.925B |
| June 30, 2016 | 6.831B |
| March 31, 2016 | 6.855B |
| December 31, 2015 | 6.567B |
| September 30, 2015 | 6.348B |
| June 30, 2015 | 6.344B |
| March 31, 2015 | 6.574B |
| December 31, 2014 | 6.003B |
| September 30, 2014 | 5.679B |
| June 30, 2014 | 4.943B |
| March 31, 2014 | 5.461B |
| December 31, 2013 | 5.140B |
| September 30, 2013 | 5.249B |
| June 30, 2013 | 5.055B |
| March 31, 2013 | 4.923B |
| December 31, 2012 | 4.438B |
| September 30, 2012 | 5.361B |
| June 30, 2012 | 4.961B |
| March 31, 2012 | 5.163B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.20B
Minimum
Dec 2019
36.87B
Maximum
Jun 2024
20.28B
Average
19.60B
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Evaxion Biotech AS | 13.98M |
| Amgen Inc | 83.36B |
| Viking Therapeutics Inc | 26.44M |
| Adaptimmune Therapeutics PLC | 225.43M |
| Genfit SA | 117.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 53.03B |
| Shareholders Equity (Quarterly) | 16.15B |
| Debt to Equity Ratio | 0.5071 |
| Current Ratio | 0.9446 |
| Net Debt Paydown Yield | -0.14% |